Fri, July 15, 2022
Thu, July 14, 2022
Wed, July 13, 2022
Tue, July 12, 2022

Amit Hazan Maintained (TXG) at Hold with Decreased Target to $60 on, Jul 14th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-60-on-jul-14th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Amit Hazan of Goldman Sachs, Maintained "10x Genomics, Inc." (TXG) at Hold with Decreased Target from $80 to $60 on, Jul 14th, 2022.

Amit has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 0 agree with Amit's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Amit


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $100 on, Friday, May 6th, 2022
  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, May 5th, 2022

Publication Contributing Sources